MBTPS1 and Alzheimer disease: Furthermore, because chronic neuroinflammation is a well-established pathogenic factor for both AD and CeVD [9–11], our data also support further assessment of S1P (as well as their receptors and associated metabolic pathways) as potential therapeutic targets for these conditions.